Density of mu-opioid receptors in the hippocampus of adult male and female rats is altered by prenatal morphine exposure and gonadal hormone treatment.
The present in vitro autoradiography study demonstrates that prenatal exposure to morphine alters the density of mu-opioid receptors in the hippocampus of adult female but not adult male rats. Prenatal morphine exposure increased the mu-opioid receptor density in the CA1 of ovariectomized (OVX) females and in the CA3 of OVX, estradiol benzoate-plus progesterone (EB+P)-treated females, but decreased it in CA3 of OVX females. There were also hormonal effects on mu-opioid receptor density in adult female rats. In the CA1, only morphine-exposed but not saline-exposed, hormone-treated females (EB, P, or EB+P) had a decrease in mu-opioid receptor density relative to OVX females. Both saline-exposed and morphine-exposed, OVX females after gonadal hormone replacement had a lower density of mu-opioid receptors in the CA3 and in the dentate gyrus (DG) than OVX females. In male rats, there was a decrease in mu-opioid receptor density in the CA1 and CA3 of gonadectomized (GNX), testosterone 17beta-proprionate (TP)-treated males relative to GNX males regardless of prenatal morphine exposure. In the DG, the mu-opioid receptor density was reduced only in morphine-exposed but not in saline-exposed, TP-treated males compared with GNX males. Thus, our data demonstrate that mu-opioid receptor density in the hippocampus is affected by prenatal morphine exposure and by male and female gonadal hormones.
Slamberová
Romana
R
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Rimanóczy
Agnes
A
Bar
Noffar
N
Schindler
Cheryl J
CJ
Vathy
Ilona
I
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D004967:Estrogens / Q000172:deficiency / Q000494:pharmacology; D005260:Female; D012739:Gonadal Steroid Hormones / Q000172:deficiency* / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects* / Q000196:embryology / Q000378:metabolism; D008297:Male; D009020:Morphine / Q000009:adverse effects*; D009021:Morphine Dependence / Q000150:complications*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009919:Orchiectomy; D010052:Ovariectomy; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011374:Progesterone / Q000172:deficiency / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017450:Receptors, Opioid, mu / Q000187:drug effects* / Q000378:metabolism; D012727:Sex Characteristics; D013739:Testosterone / Q000172:deficiency / Q000494:pharmacology; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
D004967:Estrogens; D012739:Gonadal Steroid Hormones; D017450:Receptors, Opioid, mu; D013739:Testosterone; D011374:Progesterone; D009020:Morphine